marketcaparena

STIM

Neuronetics, Inc.

Company overview

Market capitalization
$194.68M
Employees
658
Latest publication
2026-09-29
About Neuronetics, Inc.

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ4 20162016-12-31 · USDQ3 20162016-09-30 · USDQ2 20162016-06-30 · USDQ1 20162016-03-31 · USD
Total Revenue41,568,000USD9,815,000USD8,280,000USD9,276,000USD6,857,000USD
Cost Of Revenue20,345,000USD2,169,000USD1,429,000USD1,667,000USD1,357,000USD
Gross Profit21,223,000USD27,606,000USD0USD0USD0USD
Research Development1,336,000USD2,217,000USD1,885,000USD2,163,000USD1,958,000USD
Selling General Administrative11,404,000USD11,241,000USD8,809,000USD8,910,000USD7,983,000USD
Selling And Marketing Expenses9,984,000USD————
General And Administrative Expenses11,404,000USD————
Total Operating Expenses22,724,000USD43,565,000USD0USD0USD0USD
Operating Income-1,501,000USD-9,337,000USD0USD0USD0USD
Total Other Income Expense Net162,000USD-1,897,000USD0USD0USD0USD
Interest Expense2,125,000USD555,000USD459,000USD411,000USD410,000USD
Net Income-3,464,000USD-11,234,000USD0USD0USD0USD
Minority Interest-25,000USD0USD0USD0USD0USD
Net Income Applicable To Common Shares-3,439,000USD-11,234,000USD0USD0USD0USD
Unclassified Operating Expenses—30,107,000USD-10,694,000USD-11,073,000USD-9,941,000USD
Income Before Tax—-11,234,000USD0USD0USD0USD
Income Tax Expense—0USD0USD0USD0USD
Net Income From Continuing Ops—-11,234,000USD0USD0USD0USD
Ebit—-9,337,000USD0USD0USD0USD
Discontinued Operations—0USD0USD0USD0USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets131,529,000USD125,440,000USD141,551,000USD145,465,000USD134,650,000USD141,988,000USD140,903,000USD74,117,000USD
Cash And Equivalents19,197,000USD———————
Total Current Assets53,230,000USD47,175,000USD61,551,000USD64,888,000USD56,139,000USD60,668,000USD58,122,000USD53,459,000USD
Other Current Assets3,505,000USD13,179,999USD5,972,000USD6,734,000USD6,908,000USD8,281,000USD9,924,000USD7,758,000USD
Other Non Current Assets2,792,000USD———————
Total Liabilities109,889,000USD———————
Total Current Liabilities28,309,000USD28,285,000USD30,521,000USD28,940,000USD27,803,000USD24,841,000USD31,265,000USD16,897,000USD
Other Current Liabilities425,000USD———————
Other Non Current Liabilities142,000USD———————
Total Stockholder Equity17,850,000USD13,265,000USD22,378,000USD27,356,000USD27,147,000USD35,452,000USD27,706,000USD9,381,000USD
Total Equity Including Noncontrolling Interest21,640,000USD———————
Long Term Debt61,519,000USD61,297,000USD65,807,000USD65,671,000USD55,539,000USD55,341,000USD55,151,000USD46,002,000USD
Deferred Revenue1,143,000USD———————
Net Receivables15,955,000USD16,065,999USD16,893,000USD19,186,000USD26,643,000USD26,892,000USD24,285,000USD19,302,000USD
Inventory5,502,000USD4,715,000USD4,327,000USD4,322,000USD4,943,000USD4,069,000USD4,248,000USD4,960,000USD
Property Plant Equipment Net27,377,000USD26,943,000USD28,026,000USD29,171,000USD29,804,000USD32,550,000USD33,335,000USD3,967,000USD
Goodwill23,622,000USD———————
Intangible Assets17,420,000USD17,785,000USD18,149,000USD19,113,000USD18,878,000USD19,242,000USD19,606,000USD—
Accounts Payable12,419,000USD11,433,000USD10,739,000USD11,573,000USD9,725,000USD8,482,000USD11,077,000USD3,295,000USD
Short Term Debt5,143,000USD5,422,000USD5,561,000USD5,584,000USD5,317,000USD4,922,000USD4,791,000USD862,000USD
Common Stock762,000USD696,000USD690,000USD685,000USD661,000USD658,000USD557,000USD303,000USD
Retained Earnings-473,151,000USD-469,577,000USD-458,787,000USD-451,629,000USD-442,584,000USD-432,464,000USD-419,789,000USD-407,127,000USD
Total Liab—108,380,000USD115,311,000USD114,105,000USD103,143,000USD102,457,000USD109,104,000USD64,736,000USD
Other Current Liab—10,597,000USD13,468,000USD11,029,000USD11,305,000USD10,079,000USD13,804,000USD10,715,000USD
Capital Stock—696,000USD690,000USD685,000USD661,000USD658,000USD557,000USD303,000USD
Good Will—23,622,000USD23,622,000USD22,664,000USD19,079,000USD18,634,000USD18,634,000USD—
Cash—13,214,000USD34,134,000USD34,471,000USD17,469,000USD21,224,000USD19,459,000USD20,867,000USD
Cash And Short Term Investments—13,214,000USD34,359,000USD34,646,000USD17,645,000USD21,426,000USD19,665,000USD21,439,000USD
Current Deferred Revenue—833,000USD753,000USD754,000USD894,000USD785,000USD974,000USD1,311,000USD
Net Debt—72,174,000USD56,169,000USD56,278,000USD63,188,000USD61,314,000USD63,169,000USD27,830,000USD
Short Long Term Debt Total—85,388,000USD90,303,000USD90,749,000USD80,657,000USD82,538,000USD82,628,000USD48,697,000USD
Long Term Investments—108,000USD98,000USD94,000USD103,000USD74,000USD86,000USD140,000USD
Short Term Investments—257,000USD225,000USD175,000USD176,000USD202,000USD206,000USD572,000USD
Property Plant Equipment Gross—30,768,000USD32,078,000USD33,107,000USD33,554,000USD36,120,000USD36,579,000USD7,323,000USD
Common Stock Shares Outstanding—69,589,000shares68,756,000shares67,309,000shares66,180,000shares61,465,000shares36,674,000shares30,267,000shares
Non Current Assets Total—78,265,000USD80,000,000USD80,577,000USD78,511,000USD81,320,000USD82,781,000USD20,658,000USD
Non Current Liabilities Total—80,095,000USD84,790,000USD85,165,000USD75,340,000USD77,616,000USD77,839,000USD47,839,000USD
Non Current Liabilities Other—71,000USD——————
Non Currrent Assets Other—9,807,000USD9,954,000USD9,629,000USD10,647,000USD10,820,000USD11,120,000USD16,551,000USD
Net Working Capital—18,890,000USD31,030,000USD35,948,000USD28,336,000USD35,827,000USD26,857,000USD36,562,000USD
Unclassified Non Current Liabilities—18,727,000USD18,983,000USD19,494,000USD19,801,000USD22,275,000USD22,688,000USD1,837,000USD
Unclassified Equity—481,450,000USD479,785,000USD477,615,000USD468,409,000USD466,600,000USD446,381,000USD415,902,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets141,551,000USD140,903,000USD115,831,000USD116,884,000USD141,223,000USD78,657,000USD100,168,000USD117,022,000USD
Intangible Assets18,149,000USD19,606,000USD4,200,000USD3,600,000USD2,500,000USD1,200,000USD1,200,000USD1,000,000USD
Other Current Assets5,972,000USD9,924,000USD7,280,000USD4,171,000USD4,649,000USD3,282,000USD2,519,000USD1,838,000USD
Total Liab115,311,000USD109,104,000USD81,641,000USD59,824,000USD56,048,000USD53,164,000USD52,316,000USD45,980,000USD
Total Stockholder Equity22,378,000USD27,706,000USD34,190,000USD57,060,000USD85,175,000USD25,493,000USD47,852,000USD71,042,000USD
Other Current Liab13,468,000USD13,804,000USD11,777,000USD14,178,000USD7,569,000USD6,593,000USD8,331,000USD6,942,000USD
Common Stock690,000USD557,000USD291,000USD273,000USD264,000USD191,000USD186,000USD177,000USD
Capital Stock690,000USD557,000USD291,000USD273,000USD264,000USD191,000USD186,000USD177,000USD
Retained Earnings-458,787,000USD-419,789,000USD-376,081,000USD-345,892,000USD-308,733,000USD-277,540,000USD-250,087,000USD-221,043,000USD
Good Will23,622,000USD18,634,000USD0USD—————
Cash34,134,000USD19,459,000USD59,677,000USD70,340,000USD94,141,000USD48,957,000USD75,708,000USD104,583,000USD
Cash And Short Term Investments34,359,000USD19,665,000USD60,582,000USD71,878,000USD96,339,000USD50,844,000USD76,588,000USD104,583,000USD
Total Current Assets61,551,000USD58,122,000USD93,793,000USD98,769,000USD115,331,000USD65,012,000USD88,451,000USD114,473,000USD
Total Current Liabilities30,521,000USD31,265,000USD19,812,000USD33,199,000USD15,703,000USD13,682,000USD27,693,000USD13,559,000USD
Current Deferred Revenue753,000USD974,000USD1,620,000USD1,980,000USD2,501,000USD2,020,000USD2,228,000USD2,255,000USD
Net Debt56,169,000USD63,169,000USD2,797,000USD-30,595,000USD-54,597,000USD-10,622,000USD-41,382,000USD-74,188,000USD
Short Term Debt5,561,000USD4,791,000USD845,000USD13,949,000USD670,000USD594,000USD11,809,000USD—
Short Long Term Debt Total90,303,000USD82,628,000USD62,474,000USD39,745,000USD39,544,000USD38,335,000USD34,326,000USD30,395,000USD
Long Term Debt65,807,000USD55,151,000USD59,283,000USD22,829,000USD35,335,000USD34,620,000USD19,898,000USD30,395,000USD
Long Term Investments98,000USD86,000USD661,000USD362,000USD1,697,000USD2,331,000USD1,730,000USD—
Short Term Investments225,000USD206,000USD905,000USD1,538,000USD2,198,000USD1,887,000USD880,000USD—
Net Receivables16,893,000USD24,285,000USD17,838,000USD13,821,000USD7,780,000USD7,166,000USD6,569,000USD5,620,000USD
Inventory4,327,000USD4,248,000USD8,093,000USD8,899,000USD6,563,000USD3,720,000USD2,775,000USD2,432,000USD
Accounts Payable10,739,000USD11,077,000USD4,752,000USD2,433,000USD4,299,000USD3,749,000USD4,625,000USD3,756,000USD
Property Plant Equipment Net28,026,000USD33,335,000USD4,782,000USD5,318,000USD5,104,000USD4,148,000USD4,903,000USD1,378,000USD
Property Plant Equipment Gross32,078,000USD36,579,000USD7,604,000USD5,318,000USD5,104,000USD4,148,000USD4,903,000USD1,378,000USD
Common Stock Shares Outstanding65,951,000shares31,734,000shares28,658,000shares26,900,000shares25,479,000shares18,835,000shares18,380,000shares8,948,000shares
Non Current Assets Total80,000,000USD82,781,000USD22,038,000USD18,115,000USD25,892,000USD13,645,000USD11,717,000USD2,549,000USD
Non Current Liabilities Total84,790,000USD77,839,000USD61,829,000USD26,625,000USD40,345,000USD39,482,000USD24,623,000USD32,421,000USD
Non Currrent Assets Other9,954,000USD11,120,000USD16,595,000USD11,575,000USD19,091,000USD7,166,000USD5,084,000USD171,000USD
Net Working Capital31,030,000USD26,857,000USD73,981,000USD65,570,000USD99,628,000USD51,330,000USD60,758,000USD100,914,000USD
Unclassified Non Current Liabilities18,983,000USD22,688,000USD2,546,000USD—-3,224,000USD-1,741,000USD-3,779,000USD-2,026,000USD
Unclassified Equity479,785,000USD446,381,000USD409,689,000USD402,406,000USD393,380,000USD302,651,000USD299,774,000USD293,747,000USD
Other Assets——1USD9,197,000USD167,115,000USD12,915,000USD5,614,000USD171,000USD
Unclassified Non Current Assets——-4,200,001USD-11,937,000USD-169,615,000USD-14,115,000USD-6,814,000USD—
Deferred Long Term Liab———829,000USD6,763,000USD1,741,000USD3,779,000USD2,026,000USD
Other Liab———829,000USD1,471,000USD1,741,000USD2,106,000USD2,026,000USD
Short Long Term Debt———13,125,000USD——11,250,000USD—
Non Current Liabilities Other———2,967,000USD—3,121,000USD2,619,000USD—
Net Tangible Assets———57,060,000USD85,175,000USD25,493,000USD46,652,000USD70,042,000USD
Unclassified Current Liabilities———-12,466,000USD——-10,550,000USD—
Accumulated Other Comprehensive Income—————0USD-2,207,000USD-2,016,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation1,474,000USD
Stock Based Compensation2,365,000USD
Other Non Cash Items-539,000USD
Change To Account Receivables893,000USD
Change To Inventory-1,289,000USD
Change To Liabilities-1,899,000USD
Change In Working Capital1,091,000USD
Operating Cash Flow-10,429,000USD
Capital Expenditures-614,000USD
Unclassified Investing Cash Flow25,000USD
Investing Cash Flow-589,000USD
Net Debt Issuance-5,000,000USD
Other Financing Activities-192,000USD
Unclassified Financing Cash Flow7,023,000USD
Financing Cash Flow1,831,000USD
Change In Cash-9,187,000USD
End Cash Flow24,947,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-10,790,000USD-7,487,000USD-9,120,000USD-10,120,000USD-12,689,000USD-12,681,000USD-13,341,000USD-9,832,000USD
Depreciation745,000USD767,000USD886,000USD901,000USD911,000USD446,000USD512,000USD555,000USD
Stock Based Compensation1,677,000USD2,181,000USD1,409,000USD1,814,000USD1,444,000USD1,282,000USD1,419,000USD1,563,000USD
Other Non Cash Items2,455,000USD858,000USD322,000USD778,000USD194,000USD4,563,000USD5,494,000USD1,008,000USD
Change To Account Receivables1,008,000USD2,157,000USD3,863,000USD148,000USD-2,627,000USD107,000USD-630,000USD-537,000USD
Change To Inventory-432,000USD-155,000USD551,000USD-966,000USD175,000USD432,000USD874,000USD516,000USD
Change In Working Capital-1,831,000USD4,589,000USD5,718,000USD3,123,000USD-6,853,000USD-2,206,000USD499,000USD1,737,000USD
Total Cash From Operating Activities-9,421,000USD908,000USD-785,000USD-3,504,000USD-16,993,000USD-8,596,000USD-5,417,000USD-4,969,000USD
Capital Expenditures-197,000USD-216,000USD-114,000USD-252,000USD-219,000USD-89,000USD-386,000USD-616,000USD
Free Cash Flow-9,618,000USD692,000USD-899,000USD-3,756,000USD-17,212,000USD-8,685,000USD-5,803,000USD-5,585,000USD
Total Cashflows From Investing Activities-172,000USD-215,000USD-114,000USD-252,000USD-219,000USD-2,376,000USD14,000USD-119,000USD
Net Borrowings-5,000,000USD-211,000USD——0USD9,395,000USD-11,916,000USD—
Total Cash From Financing Activities-5,577,000USD-1,029,000USD17,901,000USD1,000USD18,977,000USD9,564,000USD-16,372,000USD0USD
Issuance Of Capital Stock0USD0USD8,313,000USD0USD20,700,000USD——0USD
Change In Cash-15,170,000USD-337,000USD17,002,000USD-3,755,000USD1,765,000USD-1,408,000USD-21,775,000USD-5,088,000USD
Begin Period Cash Flow34,134,000USD34,471,000USD17,469,000USD21,224,000USD19,459,000USD20,867,000USD42,642,000USD47,730,000USD
End Period Cash Flow18,964,000USD34,134,000USD34,471,000USD17,469,000USD21,224,000USD19,459,000USD20,867,000USD42,642,000USD
Other Cashflows From Investing Activities-25,000USD46,000USD-10,000USD-12,000USD—-2,287,000USD400,000USD497,000USD
Other Cashflows From Financing Activities-577,000USD-594,000USD—1,000USD-1,723,000USD-436,000USD-4,456,000USD-119,000USD
Unclassified Operating Cash Flow-1,677,000USD———————
Investments——-114,000USD-252,000USD-219,000USD-2,376,000USD14,000USD-119,000USD
Unclassified Financing Cash Flow——9,588,000USD—————
Unclassified Investing Cash Flow—————2,376,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-39,135,000USD-43,727,000USD-30,189,000USD-37,159,000USD-31,193,000USD-27,453,000USD-29,044,000USD-24,097,000USD
Depreciation3,465,000USD2,073,000USD2,006,000USD1,648,000USD1,060,000USD941,000USD1,065,000USD882,000USD
Stock Based Compensation6,848,000USD5,602,000USD7,319,000USD8,746,000USD7,869,000USD4,404,000USD3,434,000USD1,743,000USD
Other Non Cash Items1,871,000USD11,863,000USD2,929,000USD1,142,000USD918,000USD1,993,000USD976,000USD1,068,000USD
Change To Account Receivables3,541,000USD-3,727,000USD-8,831,000USD-6,658,000USD-3,054,000USD-597,000USD-950,000USD-1,353,000USD
Change To Inventory-395,000USD3,150,000USD-1,098,000USD-2,587,000USD-3,444,000USD-945,000USD-306,000USD-435,000USD
Change In Working Capital6,577,000USD-6,808,000USD-14,103,000USD-5,116,000USD-6,637,000USD-8,275,000USD-6,913,000USD-1,583,000USD
Total Cash From Operating Activities-20,374,000USD-30,997,000USD-32,038,000USD-30,739,000USD-27,983,000USD-28,390,000USD-30,482,000USD-20,591,000USD
Capital Expenditures-801,000USD-1,466,000USD-2,369,000USD-3,269,000USD-2,353,000USD-730,000USD-813,000USD-1,011,000USD
Free Cash Flow-21,175,000USD-32,463,000USD-34,407,000USD-34,008,000USD-30,336,000USD-29,120,000USD-31,295,000USD-21,602,000USD
Total Cashflows From Investing Activities-801,000USD-2,413,000USD-1,322,000USD6,731,000USD-9,839,000USD-730,000USD-813,000USD-1,011,000USD
Net Borrowings9,789,000USD-2,521,000USD23,800,000USD-91,000USD0USD1,679,000USD2,500,000USD2,500,000USD
Total Cash From Financing Activities35,850,000USD-6,808,000USD22,697,000USD207,000USD83,006,000USD2,369,000USD2,420,000USD97,038,000USD
Sale Purchase Of Stock-1,731,000USD0USD0USD298,000USD—690,000USD2,420,000USD97,038,000USD
Issuance Of Capital Stock29,013,000USD0USD0USD0USD80,972,000USD0USD0USD99,998,000USD
Change In Cash14,675,000USD-40,218,000USD-10,663,000USD-23,801,000USD45,184,000USD-26,751,000USD-28,875,000USD75,436,000USD
Begin Period Cash Flow19,459,000USD59,677,000USD70,340,000USD94,141,000USD48,957,000USD75,708,000USD104,583,000USD29,147,000USD
End Period Cash Flow34,134,000USD19,459,000USD59,677,000USD70,340,000USD94,141,000USD48,957,000USD75,708,000USD104,583,000USD
Other Cashflows From Investing Activities31,000USD1,606,000USD1,047,000USD10,000,000USD-7,810,000USD1,609,000USD2,610,000USD-7,486,000USD
Other Cashflows From Financing Activities-594,000USD-4,287,000USD-1,103,000USD207,000USD2,034,000USD-131,000USD2,420,000USD-2,960,000USD
Unclassified Financing Cash Flow28,386,000USD—————-4,920,000USD—
Investments—-2,413,000USD-1,322,000USD10,000,000USD-9,839,000USD-730,000USD-813,000USD-1,011,000USD
Unclassified Investing Cash Flow——1,322,000USD-10,000,000USD10,163,000USD—-1,797,000USD8,497,000USD
Change To Liabilities———4,636,000USD491,000USD-2,818,000USD1,848,000USD505,000USD
Cash And Cash Equivalents Changes———-23,801,000USD—-26,751,000USD-28,875,000USD75,436,000USD
Unclassified Operating Cash Flow———————1,396,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31ProductProduct12,925,000USD0001104659-26-055322
Q1 2026Quarterly · 2026-03-31ProductServices21,529,000USD0001104659-26-055322
Q1 2026Quarterly · 2026-03-31SegmentClinical Services21,529,000USD0001104659-26-055322
Q1 2026Quarterly · 2026-03-31SegmentMedical Device12,925,000USD0001104659-26-055322
FY 2025Yearly · 2025-12-31ProductProduct62,180,000USD0001104659-26-029004
FY 2025Yearly · 2025-12-31ProductServices86,977,000USD0001104659-26-029004
FY 2025Yearly · 2025-12-31SegmentClinical Services86,977,000USD0001104659-26-029004
FY 2025Yearly · 2025-12-31SegmentMedical Device62,180,000USD0001104659-26-029004
Q1 2025Quarterly · 2025-03-31ProductProduct13,316,000USD0001104659-26-055322
Q1 2025Quarterly · 2025-03-31ProductServices18,659,000USD0001104659-26-055322
Q1 2025Quarterly · 2025-03-31SegmentClinical Services18,659,000USD0001104659-26-055322
Q1 2025Quarterly · 2025-03-31SegmentMedical Device13,316,000USD0001104659-26-055322
FY 2024Yearly · 2024-12-31ProductProduct70,445,000USD0001104659-26-029004
FY 2024Yearly · 2024-12-31ProductServices4,445,000USD0001104659-26-029004
FY 2024Yearly · 2024-12-31SegmentClinical Services4,445,000USD0001104659-26-029004
FY 2024Yearly · 2024-12-31SegmentMedical Device70,445,000USD0001104659-26-029004
FY 2018Yearly · 2018-12-31GeographyInternational1,299,000USD0001564590-19-006276
FY 2018Yearly · 2018-12-31GeographyUnited States51,477,000USD0001564590-19-006276
Q3 2018Quarterly · 2018-09-30GeographyInternational219,000USD0001564590-18-027435
Q3 2018Quarterly · 2018-09-30GeographyUnited States13,518,000USD0001564590-18-027435
Q2 2018Quarterly · 2018-06-30GeographyInternational354,000USD0001564590-18-021702
Q2 2018Quarterly · 2018-06-30GeographyUnited States12,898,000USD0001564590-18-021702
FY 2017Yearly · 2017-12-31GeographyInternational580,000USD0001564590-19-006276
FY 2017Yearly · 2017-12-31GeographyUnited States39,853,000USD0001564590-19-006276
Q3 2017Quarterly · 2017-09-30GeographyInternational93,000USD0001564590-18-027435
Q3 2017Quarterly · 2017-09-30GeographyUnited States10,398,000USD0001564590-18-027435
Q2 2017Quarterly · 2017-06-30GeographyInternational83,000USD0001564590-18-021702
Q2 2017Quarterly · 2017-06-30GeographyUnited States10,225,000USD0001564590-18-021702

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.